Fingerprint
Dive into the research topics of 'Anti-TNF, infliximab, and adalimumab can be effective in eosinophilic bowel disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Anti-TNF, infliximab, and adalimumab can be effective in eosinophilic bowel disease
Dan Turner*, Victorien M. Wolters, Richard K. Russell, Valentina Shakhnovich, Aleixo M. Muise, Oren Ledder, Bo Ngan, Craig Friesen
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
26
Scopus
citations